GEN Exclusives

More »

The Lists

More »
Sep 9, 2013

Top 20 CEO Salaries: Biotech Tool Providers

Running a large instrumentation company is not a bad-paying job as these 20 men can attest.

Top 20 CEO Salaries: Biotech Tool Providers

Less than half of the CEOs on this list saw their total compensation increase over the previous year. Find out which ones did below. [© ALYUSHIN - Fotolia.com]

  • Following is a list of 20 current or former CEOs of life sciences tools and technologies providers who led their companies for at least part of 2012, ranked by their "total compensation" last year. Total compensation goes beyond salary to include bonuses, stock awards, stock option awards, nonequity incentive plan compensation, and all other sources of compensation. For each CEO ranked, the list offers 2012 and 2011 compensation, the percentage change between the amounts.

    This year, unlike last year, rankings are of individuals rather than companies to align with GEN’s similarly reranked list of biopharma CEOs published earlier this year. Also unlike GEN’s first such list in 2012 (See "Top 15 CEO Salaries: Biotech Tool Providers", published September 11, 2012, in GEN), less than half (eight of 20 CEOs) saw their total compensation increase over the previous year, compared with 10 of the top 15 CEOs ranked by GEN in 2011.

    One possible reason: Most tools companies focused more of their spending on R&D (See "Top 22 R&D Spenders among Tool and Technologies Companies," published in GEN April 2, 2013). Another possibility: Tools and tech companies opted to use cash on hand for acquisitions as the segment consolidates among fewer players, reflected best by Thermo Fisher Scientific’s plans announced in April to acquire Life Technologies.

    Four of this year’s Top 20 CEOs either assumed their positions or added to their responsibilities in 2011 or 2012. As with the biopharma CEO pay list, all of the top-paid tools-tech CEOs were male.

  • #20. Frank Witney, Ph.D.

    President and CEO of Affymetrix

    2012 Compensation: $657,291

    2011 Compensation: $2,739,8351,2

    % Change: -76.0%

  • #19. Douglas A. Berthiaume

    Chairman, President, and CEO of Waters

    2012 Compensation: $1,062,972

    2011 Compensation: $2,646,730

    % Change: -59.8%

  • #18. Gajus V. Worthington

    President and CEO of Fluidigm

    2012 Compensation: $1,352,917

    2011 Compensation: $1,108,469

    % Change: 22.1%

  • #17. Peer M. Schatz

    Managing Director, CEO of Qiagen

    2012 Compensation: $1,399,000

    2011 Compensation: $1,845,000

    % Change: -24.2%

  • #16. Frank Laukien

    Chairman, President, and CEO of Bruker

    2012 Compensation: $1,860,6023

    2011 Compensation: $892,100

    % Change: 108.6%

  • #15. Max Carnecchia

    President and CEO of Accelrys

    2012 Compensation: $1,881,828

    2011 Compensation: $1,486,023

    % Change: 26.6%

  • #14. Michael W. Hunkapiller, Ph.D.

    President, CEO, and Chairman of the Board of Directors of Pacific Biosciences

    2012 Compensation: $2,177,0024

    2011 Compensation: N/A

    % Change: N/A

  • #13. Harry F. Hixson, Jr.

    CEO of Sequenom

    2012 Compensation: $2,368,033

    2011 Compensation: $3,154,159

    % Change: -24.9%

  • #12. Patrick J. Balthrop, Sr.

    President and CEO of Luminex

    2012 Compensation: $3,214,478

    2011 Compensation: $3,782,017

    % Change: -15.0%

  • #11. John L. Bishop

    CEO and Director of Cepheid

    2012 Compensation: $3,776,595

    2011 Compensation: $4,576,225

    % Change: -17.5%

    Why do you think there aren’t more women on our list of biotech tool provider CEOs?



Related content

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Climate Change and Disease

Are the incursions of dengue fever and West Nile virus into North America just the tip of the iceberg of insect-borne diseases that are migrating due to a warming planet?